Related Experiment Video
Updated: Apr 11, 2026

07:16
Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
1.7K
A toehold-triggered switchable three-way junction protective nanoprobe for RNase H-assisted HBV rcDNA detection
Jingyi Si1,2, Suo Lv3, Yifan Gao1,2
1Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Journal of Nanobiotechnology
|April 10, 2026
Summary
This study introduces a novel DNA nanoprobe for precise hepatitis B virus (HBV) DNA quantification. The advanced assay offers high specificity and sensitivity for improved viral diagnostics.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Nanotechnology
Background:
- Chronic hepatitis B virus (HBV) infection is a major global health concern.
- Accurate quantification of HBV relaxed circular DNA (rcDNA) is crucial for disease management.
- Existing amplification methods often lack specificity, hindering accurate viral load assessment.
Purpose of the Study:
- To develop a highly specific and sensitive diagnostic platform for HBV rcDNA quantification.
- To overcome the limitations of conventional isothermal amplification techniques.
- To engineer a novel DNA nanoprobe for improved viral detection.
Main Methods:
- Designed a toehold-triggered switchable DNA three-way junction (3WJ) protective nanoprobe.
- Integrated RNase H-assisted target recycling amplification (RATRA) with toehold-mediated strand displacement (TMSD).
- Utilized a dual-verification mechanism for enhanced specificity and a nanoscale cavity for steric hindrance.
Main Results:
- Achieved a limit of detection (LOD) of 87.28 fM with a broad linear dynamic range.
- Demonstrated exceptional specificity, capable of discriminating single-base mutations.
- Clinical serum sample validation showed strong concordance with quantitative real-time PCR (qRT-PCR).
Conclusions:
- The developed nanoprobe platform offers a robust, modular, and cost-effective solution for HBV diagnostics.
- This technology holds promise for point-of-care viral detection and monitoring.
- The study presents a significant advancement in sensitive and specific nucleic acid detection.

